Back to AMGN Stock Lookup

AMGN Related Analyst Ratings

Jun 13, 2013 07:34 AM Needham & Company Sees 150% Upside in Cytokinetics (CYTK) after Expanded Amgen (AMGN) Deal

Jun 12, 2013 12:49 PM Deutsche Bank Maintains Buy on Amgen (AMGN)

Jun 3, 2013 07:39 AM Amgen (AMGN) T-VEC Data Highlighted at ASCO - Jefferies

May 1, 2013 07:20 AM Goldman Sachs Downgrades Biogen (BIIB) to Neutral, Removes from CL List

May 1, 2013 06:45 AM Goldman Sachs Upgrades Amgen (AMGN) to Conviction Buy

Apr 24, 2013 12:24 PM Amgen (AMGN) EPS Growth is 'Healthy', Target Raised - Jefferies

Apr 24, 2013 06:40 AM Piper Jaffray Downgrades Amgen (AMGN) to Neutral

Feb 19, 2013 01:02 PM Sell and Sell Aggressively, Says Carter Worth

Feb 11, 2013 08:50 AM William Blair Downgrades Amgen (AMGN) to Market Perform

Jan 25, 2013 08:14 AM Argus Upgrades Amgen (AMGN) to Buy

Jan 22, 2013 08:24 AM Credit Suisse Downgrades Amgen (AMGN) to Neutral

Dec 13, 2012 09:08 AM Goldman Sachs Resumes Amgen (AMGN) at Neutral

Nov 26, 2012 11:37 AM Oppenheimer Sees 30-35% Dividend Hike at Amgen (AMGN)

Nov 9, 2012 09:46 AM Guggenheim Starts Amgen (AMGN) at Neutral

Nov 7, 2012 10:09 AM RBC Thinks Amgen's (AMGN) AMG145 Has 'Compelling' Safety Profile Profile; Sees $10B Market Opportunity

Oct 22, 2012 10:10 AM Deutsche Bank Upgrades Amgen (AMGN) to Buy, EPS Growth and Pipeline Offers Upside

Sep 27, 2012 07:50 AM Brean Murray Carret & Co. Starts Amgen (AMGN) at Buy, Still Biotech King

Sep 14, 2012 03:53 PM Amgen (AMGN) Could Feel Sting as Xgeva Competitor Takes Away Sales - Analyst

Sep 12, 2012 06:34 AM Baird Downgrades Amgen (AMGN) to Neutral

Sep 10, 2012 12:55 PM UBS on U.S. Biotechnology - Updating Outlook on Covered Stocks (GILD, AMGN, BIIB, CELG, INCY, IDIX, VRTX, SGEN)

Sep 10, 2012 12:22 PM UPDATE: UBS Upgrades Amgen (AMGN) to Buy; Pipeline Visibility Higher

Aug 7, 2012 06:52 AM Lazard Capital Upgrades Amgen (AMGN) to Buy

Aug 2, 2012 10:21 AM Canaccord Genuity Maintains a 'Buy' on NPS Pharmaceuticals (NPSP); On the Shoulders of Gattex

Aug 2, 2012 07:51 AM Argus Downgrades Amgen (AMGN) to Hold

Aug 1, 2012 09:14 AM Canaccord Genuity Reiterates a 'Buy' on Cytokinetics (CYTK); Keep Moving Forward

Jul 27, 2012 11:36 AM Deutsche Bank Maintains a 'Hold' on Amgen (AMGN); Legacy Business and Prolia Show Signs of Life

Jul 27, 2012 07:42 AM Piper Jaffray Upgrades Amgen (AMGN) to Overweight

Jul 27, 2012 07:09 AM Baird on Amgen's (AMGN) Blow-out Q2: Not Same Old Risk/Reward, But See Mid-$80's Near-Term

Jul 25, 2012 06:51 AM Credit Suisse Upgrades Amgen (AMGN) to Outperform

Jul 18, 2012 07:41 AM Jefferies Raises Price Target and Estimates on Amgen (AMGN), Citing AMG-145 (PCSK9 Inhibitor) Potential

Jul 16, 2012 07:31 AM Baird Reiterates an 'Outperform' on Amgen (AMGN); Anticipate a Strong Q212

Jun 19, 2012 09:14 AM Medivation (MDVN) Makes The Best Takeover Target, Not Dendreon (DNDN) - Jefferies

Jun 8, 2012 01:42 PM Baird Defends Amgen (AMGN); EVOLVE Miss Isn't Dire Straights, But Does Remove A Source of Upside

Jun 8, 2012 11:52 AM Wedbush Says Buy the Dip in NPS Pharma (NPSP) Shares; Amgen's Missed Goal Does Not Impact Royalty Stream

May 21, 2012 12:17 PM Analyst Sees Affymax's (AFFY) Omontys as Comparable to Amgen's (AMGN) Epogen; Raises AFFY Target to $21

May 11, 2012 01:26 PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium

Apr 26, 2012 12:59 PM UBS Maintains a 'Neutral' on Amgen (AMGN); Updating Model: Raising PT and 2012 EPS Estimates

Mar 15, 2012 07:48 AM Stifel Nicolaus Initiates/Restarts BIIB, AFFY, CELG, GILD, ACOR, ARQL, ARIA, EXEL, BSTC at Buy, AMGN, DNDN at Hold

Mar 12, 2012 10:57 AM Auriga Reiterates a 'Buy' on Affymax, Inc. (AFFY); Raising PT Ahead of Peginesatide's March 27 PDUFA

Mar 6, 2012 08:49 AM Bernstein Downgrades Amgen (AMGN) to Market Perform

Feb 10, 2012 07:05 AM Morgan Stanley Starts Amgen (AMGN) at Equalweight

Feb 9, 2012 02:26 PM UBS Adjusts Numbers on Amgen (AMGN); Tough ODAC for Xgeva

Feb 9, 2012 10:55 AM Oppenheimer Downgrades Amgen (AMGN) to Perform

Feb 7, 2012 08:28 AM Canaccord Genuity Raises Numbers on Dendreon (DNDN); Provenge Outlook Improved on Low Likelihood of New XGEVA Approval

Feb 6, 2012 05:07 PM Wedbush Starts NPS Pharmaceuticals Inc. (NPSP) at Outperform; GATTEX Up for Approval, NATPARA Next

Feb 6, 2012 09:45 AM Lazard Capital Downgrades Amgen (AMGN) to Sell

Feb 3, 2012 09:53 AM Canaccord Genuity Maintains a 'Buy' on Cytokinetics (CYTK); Focus on New CK357 ALS Phase 2 Data at AAN in April

Feb 3, 2012 08:54 AM Affymax (AFFY) Has Additional Upside - Analyst

Jan 27, 2012 09:54 AM Jefferies Raises Price Target on Amgen (AMGN) to $78

Jan 26, 2012 01:32 PM Baird maintains an 'Outperform' on Amgen (AMGN); In Front of Earnings, Micromet (MITI) Deal a Nice Tuck-In

Back to AMGN Stock Lookup